Central effect of taurine and its analogues on fever caused by intravenous leukocytic pyrogen in the rabbit.
1. Taurine infused I.C.V. after I.V. injection of leukocytic pyrogen (LP) inhibited the initial rise in body temperature and prolonged fever when infusion was stopped. 2. Similar infusion of taurine also inhibited the hypertermic effect of I.C.V. PGE2 (0.5 microgram) but did not cause prolonged hyperthermia. 3. I.C.V. administration of the taurine analogues hypotaurine and beta-alanine, compounds which have been shown previously to compete with taurine for facilitated transport in C.N.S. tissue, also inhibited the initial increase in body temperature and prolonged LP fever. 4. These results suggest that taurine prolongs LP fever by preferentially occupying a carrier system normally required for termination of the effects of endogenous pyrogens or related central mediators of fever. There was no evidence that taurine prolongs fever by blocking inactivation of central PGE2, a substance proposed previously to be a central mediator of fever.
D000818:Animals; D001831:Body Temperature / Q000187:drug effects*; D005334:Fever / Q000139:chemically induced / Q000503:physiopathology*; D007276:Injections, Intraventricular; D008297:Male; D011458:Prostaglandins E; D011749:Pyrogens; D011817:Rabbits; D013654:Taurine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology*; D015091:beta-Alanine / Q000494:pharmacology
D011458:Prostaglandins E; D011749:Pyrogens; D015091:beta-Alanine; D013654:Taurine